BrightSpring Health Services (NASDAQ:BTSG) Issues Earnings Results, Beats Expectations By $0.07 EPS

BrightSpring Health Services (NASDAQ:BTSG) posted its quarterly earnings results on Friday. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07, FiscalAI reports. The firm had revenue of $4.21 billion during the quarter, compared to analysts’ expectations of $3.88 billion. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%. The company’s revenue for the quarter was up 26.4% on a year-over-year basis.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• Strong third-quarter performance: Revenue rose 26% year over year to $4.2 billion, adjusted EBITDA increased 42% to $228 million, and adjusted EPS grew 80% to $0.54. Results exceeded the company’s forecast, supported by broad-based growth across Pharmacy Solutions and Provider Services.
• Specialty and infusion pharmacy revenue grew 34%, driven by 29% script growth, strong branded limited-distribution drug launches, generic contributions, pharma services, and mid-teens growth in acute and chronic infusion. BrightSpring launched seven additional LDDs during the quarter and now supports 162 total therapies.
• Provider Services revenue increased 31%, with home health census up approximately 58% and continued momentum in rehab and personal care. Management expects the acquired Amedisys and LHC branches to contribute approximately $35 million of adjusted EBITDA in 2026.
• BrightSpring raised or reaffirmed a strong outlook, projecting 2026 adjusted EBITDA of $850 million-$860 million and more than $700 million of operating cash flow, while reiterating expectations for at least 15%-20% organic adjusted EBITDA growth in 2027. Leverage declined to 1.79 times, including the impact of $120 million in year-to-date share repurchases.
• Home and community pharmacy revenue declined 6% year over year, primarily because of approximately $50 million of quarterly impact from the Inflation Reduction Act and exits from uneconomic customers. Management expects the IRA to remain a roughly $50 million headwind in the fourth quarter, although underlying growth and profitability are improving.

BrightSpring Health Services Trading Up 11.1%

NASDAQ BTSG opened at $66.89 on Friday. The stock has a market capitalization of $13.24 billion, a P/E ratio of 40.30, a P/E/G ratio of 0.78 and a beta of 1.87. BrightSpring Health Services has a one year low of $30.64 and a one year high of $73.75. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.59 and a quick ratio of 1.22. The business has a 50 day simple moving average of $59.94 and a 200 day simple moving average of $54.54.

Trending Headlines about BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Third-quarter earnings exceeded expectations. BrightSpring reported adjusted earnings of $0.54 per share, up from $0.30 a year earlier and above analyst estimates ranging from $0.47 to $0.49. This marked another quarterly earnings beat for the company. BrightSpring Q3 earnings and revenue results
• Positive Sentiment: Revenue growth was substantially stronger than forecast. Quarterly revenue rose 26.4% year over year to $4.21 billion, surpassing the $3.88 billion consensus estimate. The revenue performance indicates continued expansion across BrightSpring’s healthcare services platform. BrightSpring Q3 revenue report
• Positive Sentiment: Management increased full-year 2026 guidance. BrightSpring raised its revenue and adjusted EBITDA outlook, reinforcing investor confidence that operating momentum and profitability will remain strong. BrightSpring reports Q3 results and raises guidance
• Positive Sentiment: Profitability improved. BrightSpring posted a 16.73% return on equity and a 2.55% net margin, while the earnings beat and stronger revenue helped support the positive market reaction. BrightSpring bottom-line results

Wall Street Analysts Forecast Growth

BTSG has been the subject of several recent analyst reports. Raymond James Financial started coverage on shares of BrightSpring Health Services in a research note on Thursday, July 9th. They issued an “outperform” rating and a $80.00 target price for the company. Morgan Stanley increased their target price on BrightSpring Health Services from $71.00 to $80.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Weiss Ratings cut BrightSpring Health Services from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, October 15th. UBS Group boosted their target price on BrightSpring Health Services from $63.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Finally, Wells Fargo & Company lifted their price objective on shares of BrightSpring Health Services from $61.00 to $78.00 and gave the company an “overweight” rating in a report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, BrightSpring Health Services has a consensus rating of “Moderate Buy” and a consensus price target of $72.88.

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.